https://orcid.org/0000-0002-6434-9936
Figures
Abstract
Background
Now the occurrence of delirium is more concerning to clinicians and psychiatrists. It has been reported that vitamin D deficiency may be a relevant factor in the development of delirium in hospitalized patients.
Study objective
To investigate the association between vitamin D concentration and delirium in hospitalized patients.
Methods
A systematic literature search was conducted using PubMed, EMBASE, and the Cochrane Library. The primary outcome was the occurrence of delirium in the inpatient setting. Odds ratios (OR) were calculated with random or fixed effects models.
Results
In this article, we define the normal range of vitamin D concentrations as greater than 75 nmol / L, 50–75 nmol / L as vitamin D insufficiency, 25–50 nmol / L as vitamin D deficiency, and less than 25 nmol / L as vitamin D severe deficiency. The Results showed that severe vitamin D deficiency (OR: 1.98 [1.41–2.79], P<0.001) and vitamin D deficiency (OR: 1.50 [1.12–2.00], P = 0.006) were more likely to develop delirium than normal vitamin D levels. Subgroup analysis also revealed that low vitamin D concentrations were associated with a higher incidence of delirium, whether the cutoff point was 25 nmol/L (OR: 1.52 [1.40–1.64], P<0.001), 50 nmol/L (OR: 1.47 [1.19–1.82], P<0.001), or 75 nmol/L (OR: 1.54 [1.21–1.96], P<0.001). The included studies scored medium and high on the Newcastle-Ottawa quality assessment scale.
Conclusion
Compared with normal vitamin D levels, severe vitamin D deficiency and vitamin D deficiency, but not vitamin D insufficiency, are associated with a higher incidence of delirium in hospitalized patients.
Trial registration
This review was registered in the PROSPERO database under identifier CRD42021271347. https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021271347.
Citation: Fu N, Miao M, Li N, Zeng S, Zhu R, Zhang J (2023) Association between vitamin D concentration and delirium in hospitalized patients: A meta-analysis. PLoS ONE 18(2): e0281313. https://doi.org/10.1371/journal.pone.0281313
Editor: Simone Garzon, Universita degli Studi dell’Insubria, ITALY
Received: July 14, 2022; Accepted: January 19, 2023; Published: February 8, 2023
Copyright: © 2023 Fu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper and its Supporting Information files.
Funding: Supported by the National Natural Science Foundation of China (Nos.82071217 to Jiaqiang Zhang). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
1. Introduction
Delirium, occurs in hospitalized patients more often than in the elderly. It mainly shows disorders of consciousness, disorganized thinking, lack of attention, emotional disorders, etc., and is often accompanied by other symptoms, and severe cases are even life-threatening [1]. The pathophysiological causes of delirium remain unclear but are generally thought to be related to acute infections, drugs, general anesthesia, surgery, endocrine disorders, cardiovascular disease, and several other factors (hypoxic damage to the brain, poisoning) [2]. Available data suggest that deficiencies of omega-3 polyunsaturated fatty acids and B vitamins cause cardiovascular and neurological disorders, including paresthesias, memory loss, and dementia, among others [3,4]. Omega-3 polyunsaturated fatty acids, like vitamins and minerals, are essential for the human body and have anti-inflammatory and vasodilatory properties, which may protect blood vessels and maintain blood perfusion in the brain. Meanwhile, there is increasing evidence suggesting that vitamin D deficiency may have an association with delirium [5,6].
Vitamin D is a fat-soluble vitamin that has many physiological functions in the human body, such as promoting bone growth, regulating calcium and phosphorus metabolism, regulating immune function, and so on [7]. Several studies have also confirmed the potential role of vitamin D in neurological and neuropsychiatric disorders, and vitamin D may be an important regulator of brain development [8,9]. In addition to this, there is increasing evidence that the vitamin D metabolic pathway may play an important role in obstetric and gynaecological diseases and reproduction, such as endometriosis, ovarian cancer, polycystic ovary syndrome (PCOS), and even breast cancer [10,11]. There are currently no specific guidelines for vitamin D supplementation in affected women, but there should be selectivity in the decision to supplement vitamin D, as its excess may have deleterious effects on fertility [10].
25 hydroxyvitamin D (25 (OH) D) is the intermediate form of vitamin D that is converted in the liver, and it is generally considered as a marker to assess whether vitamin D is deficient [12]. According to the American Endocrine Society guidelines, a serum 25 (OH) D concentration of 25 nmol/L was defined as severe deficiency, a serum 25 (OH) D concentration of 25–50 nmol/L as deficiency, a serum 25 (OH) D concentration of 50–75 nmol/Las insufficiency, and a serum 25 (OH) D concentration of > 75 nmol/L as normal [13,14]. Its role in calcium homeostasis and bone has been extensively studied. Of course, there are also some studies showing some effects of vitamin D on cognition and delirium [5,15,16].
A review by Groves et al summarizes the association of vitamin D deficiency in adulthood with brain related adverse outcomes such as neuropsychiatric disorders and neurodegenerative diseases [17]. Qiu et al reported that preoperative vitamin D deficiency was closely related to postoperative delirium [14]. Ford et al. found that vitamin D levels are lower in patients with delirium compared to those without delirium [18]. Pilling et al. support that low levels of vitamin D are a risk factor for the delirium [19]. However, Morandi et al. concluded that low concentrations of vitamin D levels were not correlated with whether delirium developed and that 25 (OH) D levels in patients with delirium were not significantly different from those in healthy patients [20]. Several studies also did not find an association between low levels of vitamin D and cognitive decline [15,21,22]. To date, whether serum vitamin D deficiency is a risk factor for delirium has not reached a consensus, and no meta-analysis of these issues has been performed. A meta-analysis is urgently needed to resolve these controversies. Thus, we conducted a meta-analysis to investigate the association between vitamin D concentration and inpatient delirium. The primary outcome of this meta-analysis was the association between low levels of vitamin D and the risk of delirium in the inpatient setting, and the other outcomes were the relationships between other potential risk factors and the risk of delirium. We hypothesized that low vitamin D concentrations are a risk factor for delirium in hospitalized patients.
2. Methods
The current meta-analysis aims to investigate the relationship between inpatients’ delirium and low levels of vitamin D. Our systematic review was registered before the start of the literature search under the PROSPERO registration number CRD42021271347. This meta-analysis was conducted following the requirements of the MOOSE statement [23].
2.1. Eligibility criteria
Inclusive criteria: 1. population: patients with serum 25(OH)D levels detected; 2. intervention vs comparator: low levels of vitamin D vs high levels of vitamin D; 3. the outcomes were the risk of delirium in patients with low levels of vitamin D and patients with higher levels of vitamin D. Represents in the form of OR, HR, etc., or enough data to calculate OR; 4. study design: observational study.
Exclusion criteria: 1. those studies that could not provide enough data to calculate the incidence of delirium in vitamin D deficient patients. 2. animal studies, reviews, case reports, meeting abstracts and meta-analyses, etc.
2.2. Information sources
Without language restrictions, we will search the following literature databases: PubMed, EMBASE and the Cochrane Library. All the literature until September 2021 will be searched. References in the included studies were also evaluated.
2.3. Search strategy
The keywords vitamin D, 25(OH)D, VitD, 25-hydroxyvitamin D, 25OHD, vitaminD2, vitamin D3, Hydroxycholecalciferols, hypovitaminosis D, and delirium were retrieved using medical subject headings (mesh) and text words combined. S1 Table details the complete search strategy for PubMed.
2.4. Study selection
Titles and abstracts of articles were independently screened by MM and NL. Full text searches were performed for eligible articles. Any discordant opinions were discussed by all authors until consensus was reached.
2.5. Data extraction
Two authors extracted relevant information after screening the literature according to the inclusion and exclusion criteria. Author, year of publication, study type, the population included in the study, OR the value of delirium in different levels of vitamin D concentration, etc. The above data was extracted into an Excel sheet. If studies provided vitamin D concentrations of ng/ml, we performed data transformation by the formula: 1 ng/ml = 2.5 nmol/L VitD.
2.6. Methodological quality
Each enrolled article was assessed by two independent personnel using the Newcastle Ottawa scale (NOS) [12]. This scale contains study population selection, study method comparability comparison, exposure, or outcome assessment with 3-part 8 entries for a total of 9 points. The total score was 0–3 points for low-quality literature, 3–6 points for moderate-quality literature, and 6–9 points for high-quality literature. If the two investigators disagreed in the assessment of literature quality, an agreement was reached after seeking a third individual for discussion.
2.7. Statistical analysis
Statistical analysis was performed using Stata 14.0 software. To evaluate the relationship between the degree and concentration of vitamin D deficiency in patients with delirium and healthy controls, raw data from each included article was extracted S2 Table. Effect sizes for dichotomous outcomes were assessed with odds ratios (OR) and 95% confidence intervals (CI). Continuous variable outcomes were presented with the weighted mean difference (WMD) and associated 95% CI. I2 value to assess the heterogeneity of the included literature, when I2 was less than 50%, the possibility of heterogeneity among studies was low, using the fixed effect model; Otherwise, a random effects model was used. Subgroup analysis based on possible heterogeneity factors, the robustness of results, detectable with sensitive assays.
3. Results
3.1. Study selection and characteristics
According to the comprehensive search of the above databases, a total of 314 pieces of literature were screened. After checking to remove duplicates, 278 articles remained. Then, based on the inclusion and exclusion criteria, filter the title and abstract, and finally, select 12 articles. 3 articles [6,18,24] were excluded after a full-text search, 9 observational studies did the quantitative analysis. One [25] was excluded because it only provided relevant OR values, the outcome measures did not correspond, and attempts to contact the authors did not obtain the data. Finally, 8 pieces of literature [14,19,20,26–30] were included in the quantitative synthesis in the meta-analysis (Fig 1). For the final quantitative analysis, eight observational studies (three prospective, four retrospective, and one case-control study) were included. The years of publication of these observational studies were between 2013 and 2021. In one [20] of them, there is no detailed data in the literature, so only OR values were extracted.
3.2. Quality of evidence
The NOS scale was used to assess the quality of non-RCT studies, with a total of eight entries and nine assigned points (from 0 to 9 stars). The basic characteristics and NOS scores of the included articles are presented in Tables 1 and 2. After repeated evaluation by multiple researchers, the average score of NOS is 7.8, which can be considered as high-quality literature.
3.3. Evaluation of publication bias and sensitivity analysis
No publication bias was done in this paper due to the small number of included works of literature. When heterogeneity was high, a sensitivity analysis was performed. After excluding the literature by article, the results were consistent before and after the outcome measures, which indicated that the results were robust and credible (Fig 2).
3.4. Association between different levels of vitamin D concentrations and the occurrence of delirium in hospitalized patients
As shown in Fig 3, the incidence of delirium was higher in patients with severe deficiency of serum vitamin D than in those with normal vitamin D levels (OR: 1.98; 95% CI: 1.41 to 2.79; I2 = 25%, P<0.001). When serum vitamin D was deficient, the incidence of delirium was also greatly different between cases and controls (OR: 1.50; 95% CI: 1.12 to 2.00; I2 = 0.0%, P = 0.006). However, when serum vitamin D insufficiency (50–75 nmol/L) was compared with normal serum vitamin D (> 75 nmol/L), there was not statistical difference between the two groups (OR: 1.29; 95% CI: 0.97 to 1.72; I2 = 0.0%, P = 0.08). Heterogeneity I2 of less than 50% was observed at the time of meta-analysis, so we adopted a fixed-effects model.
A: <25nmol/L. B: 25-50nmol/L. C: 50-75nmol/L.
3.5. Association with delirium at different threshold concentrations of vitamin D in cases and controls
As can be seen in Fig 4, Five studies compared the incidence of delirium using a cut-off value of 25 nmol/L and showed a marked difference between groups for serum vitamin D 25 nmol/L (OR: 1.52; 95%CI: 1.40–1.64; I2 = 0%, P<0.001). Six observational studies reported the incidence of delirium at less than 50 nmol/L. The results of the meta-analysis showed a striking difference between the groups (OR: 1.47; 95%CI: 1.19–1.82; I2 = 67%, P<0.001). As I2 was greater than 50% (I2 = 67%), the random effects model was chosen to reduce heterogeneity. Three articles were included when 75 nmol/L was taken as the threshold. The results of the meta-analysis showed that there was still a striking difference in the incidence of delirium when the concentration of serum vitamin D was less than 75 nmol/L (OR: 1.54; 95%CI: 1.21–1.96; I2 = 0%, P<0.001).
A: 25nmol/L. B: 50nmol/L. C: 75nmol/L.
3.6. Subgroup analysis
When we took the 50 nmol / L as the cutoff value for statistical analysis, a large statistical heterogeneity was found (I2 = 67%). This may be due to the use of different assessment tools for delirium in the included studies, type of inpatient population, clinical setting, etc. Through subgroup analysis, different types of hospitalized patients, types of included studies, and the age difference between groups all revealed that low level of vitamin D was a risk factor for the occurrence of delirium. (Table 3). Subgroup analyses for other relevant study characteristics are detailed in Table 3.
3.7. Other potential risk factors for delirium
Analysis of risk factors for delirium showed that neither antipsychotic use, female gender, smoker, serum albumin content, nor BMI were risk factors for delirium in the inpatient setting (Table 4). However, a meta-analysis of age showed that patients with delirium were older (WMD: 4.14; 95% CI: 0.34–7.93; I2 = 89.7%, P = 0.03)
3.8. Length of hospital stay
Length of hospital stay was reported in 2 trials. Meta analysis showed that the length of hospital stay(WMD: 1.53; 95% CI: 0.55–2.51; I2 = 77.7%, P = 0.002) was significantly different between the two groups (Table 4).
4. Discussion
In recent years, many studies have evaluated the relationship between low-level vitamin D concentrations and delirium in hospitalized patients, but the results are still controversial. To pool and quantitatively evaluate the current evidence, we conducted a meta-analysis of eight studies. The main research conclusions of this paper: 1. Vitamin D deficiency and severe vitamin D deficiency are risk factors for delirium in hospitalized patients.2. There was no significant difference in the incidence of delirium between vitamin D insufficiency and normal vitamin D concentrations. According to the selection of the research population included in the article, the comparability between groups and the evaluation of results in statistical analysis, and the overall quality of evidence, varies from medium to high.
The involvement of vitamin D in various brain and neurocognitive processes has been supported by an increasing number of studies. Two meta-analyses on the relationship between Alzheimer’s disease and vitamin D concentrations also suggested that lower vitamin D concentrations were associated with a higher risk of Alzheimer’s disease [31,32]. To investigate the causal relationship between vitamin D and Alzheimer’s disease, Mendelian randomization studies [33–36] have shown an inverse causal relationship between vitamin D gene levels and Alzheimer’s disease. One [34] study confirms that genetic vitamin D levels can reduce the age threshold for risk of Alzheimer’s disease in people aged 60 years and older. Interestingly, there is one Mendelian randomization study [37] showed no association between genetic risk scores and cognitive performance for SNPs in the DHCR7 and cyp2r1 gene regions. This does not conflict with previous results, as the subjects studied were those with cognitive abilities rather than Alzheimer’s disease. The results of a meta-analysis by Goodwell et al. [16] found that low vitamin D levels were associated with poor cognitive function. Delirium and cognitive function are two mutually independent concepts whose association relationship has not been fully elucidated, but they are both behavioral manifestations of brain dysfunction. Our results showed that lower levels of vitamin D are a risk factor for delirium in hospitalized patients.
The occurrence of delirium in hospitalized patients causes great concern among physicians and patients. The mechanisms underlying the development of delirium remain poorly defined, but increasing inflammation may be an important risk factor for the development of delirium [38,39]. Regarding the contribution of neuroinflammatory pathways to promoting delirium occurrence may be relevant in elderly subjects or patients with previous dementia [39,40]. There is compelling evidence that the presence of peripheral immune signals ultimately leads to functional and structural changes in brain parenchymal cells, including microglia, astrocytes, and neurons, through a complex communication system involving the blood-brain barrier [39]. These neuroinflammatory changes are associated with acute onset of cognitive, behavioral, and mood disorders.
Several possible mechanisms for the emergence of the above results may be 1. The occurrence of delirium at low levels of vitamin D may be related to the pro-inflammatory properties of vitamin D [20]. There is one study showing that when vitamin D is deficient, intake of vitamin D can reduce the C-reactive protein ratio and reduce inflammation [41]. This may be related to the immunomodulatory (related to T cells, B cells, dendritic cells and macrophages) effects of vitamin D [42]. 2. It is already known that the vitamin D receptor can be found in nearly all regions of the brain (cortex, hippocampus, and hypothalamus, among others). Vitamin D can upregulate the expression of vitamin D receptors, thereby having neuroprotective effects against glutamate toxicity and reducing the production of oxidative stress [5]. 3. Vitamin D can influence the genetic expression of delirium-related neurotransmitters such as acetylcholine, serotonin, dopamine, and aminobutyric acid within the neural brain [5]. From the genetic level, Bowman et al. validated the relationship between vitamin D levels and delirium, showing that correcting low levels of vitamin D is necessary to prevent the occurrence of delirium [6].
Currently, opinions remain inconsistent regarding the definition of the adequacy of vitamin D levels. The UK National Institute for Health and Care Excellence considers serum 25 (OH) D levels above 50 nmol/L to be adequate [19]. The Endocrine Society’s clinical practice guidelines recommend that serum 25(OH) D concentrations greater than 75 nmol/L be considered normal [14]. Therefore, we use different cut-off points for analysis. The results showed that low vitamin D concentrations were strongly associated with the delirium in hospitalized patients, whether defined by a cut-off value of 25 nmol/L, 50 nmol/L, or 75 nmol/L. However, the study also found that vitamin D insufficiency did not increase the incidence of delirium relative to normal vitamin D. Taken together, 75 nmol/L may not be the cut-off value to judge vitamin D supplementation’s effectiveness in preventing delirium. A previous study showed that vitamin D concentrations of > 75 nmol/L are necessary for good cognitive function [43]. Our results are not consistent with the above recommendations. It may be that our subjects were patients diagnosed with delirium; it may also be that the meta-analysis included only 4 observational studies with insufficient statistical power. More randomized trial studies are needed in the future to verify this view.
However, the present study also has some limitations. First, the quality of the literature was not high; and the results were underpowered. Second, due to the wide variation in the timing of vitamin D measurement, type of inpatient, and outcome reporting across the included studies, considering the differences and the small number of included articles, we did not perform subgroup analyses. 25 hydroxyvitamin D (25 (OH) D) is the best indicator to reflect vitamin D status in humans, but large inter assay variation in results affects the clinical diagnosis of vitamin D deficiency. Currently available options are the accuracy-based vitamin D plans (ABVD) and treatments from the United Kingdom’s Vitamin D External Quality Assessment Scheme (DEQAS) and the U.S. College of American Patholo-gists(CAP) [44]. Finally, serum levels of vitamin D change dynamically during hospitalization due to various factors such as inflammatory changes, intravenous fluids, and so on. We did not evaluate the delirium effect of vitamin D over time due to limited evidence, so the conclusions should be interpreted with caution. With further enrichment of relevant literature, future meta-analyses may include this issue.
Our study is the first meta-analysis describing the relationship between vitamin D and delirium, and the results showed that vitamin D severe deficiency and vitamin D deficiency are risk factors for delirium, suggesting that it is necessary to detect serum vitamin D levels in hospitalized patients and evaluate the need for supplementation with vitamin D preparations. Healthy men seem to use 3000–5000 IU of cholecalciferol per day, which can meet more than 80% of their winter cholecalciferol requirements [45]. The recommended intake of vitamin D is now insufficient to maintain serum concentrations of 25 (OH) d in the absence of substantial amounts of vitamin D. The results of a meta-analysis [46] suggest that rapid normalization of vitamin D in the setting of acute critical illness is best achieved using a loading dose approach, with cholecalciferol of 10000 IU / kg (maximum 400000 IU) recommended most appropriately based on age or weight. The most recent review, which analyzed the efficacy and safety of calcifediol and cholecalciferol drugs in the short—and long-term, found that calcifediol was more effective with no increased toxicity [47]. A recent study also showed that rapidly increasing vitamin D levels can enhance the body’s immunity against infection [48]. This may provide a way for clinicians and psychiatrists to think about the prevention and treatment of delirium.
5. Conclusion
In conclusion, our meta-analysis of observational studies suggests that vitamin D severe deficiency and vitamin D deficiency can increase the incidence of delirium in hospitalized patients. In addition, the study also found that 75 nmol/L may not be the threshold for the need for vitamin D supplementation preparations. The studies we included were observational, and the number of pieces of literature was small. More high-quality randomized trial studies are therefore needed to confirm this.
Supporting information
S1 Table. The complete search strategy of PubMed.
https://doi.org/10.1371/journal.pone.0281313.s001
(DOCX)
S2 Table. Original data of included articles.
https://doi.org/10.1371/journal.pone.0281313.s002
(DOCX)
References
- 1. Oh ES, Fong TG, Hshieh TT, Inouye SK. Delirium in Older Persons. Jama. 2017; 318(12). https://doi.org/10.1001/jama.2017.12067.
- 2. Mattison MLP. Delirium. Ann Intern Med. 2020; 173(7): ITC49–ITC64. pmid:33017552.
- 3. Rizzo G, Lagana AS. The Link between Homocysteine and Omega-3 Polyunsaturated Fatty Acid: Critical Appraisal and Future Directions. Biomolecules. 2020; 10(2). Epub 20200202. pmid:32024302.
- 4. Rizzo G, Lagana AS, Rapisarda AM, La Ferrera GM, Buscema M, Rossetti P, et al. Vitamin B12 among Vegetarians: Status, Assessment and Supplementation. Nutrients. 2016; 8(12). Epub 20161129. pmid:27916823.
- 5. Pungsornruk K, Fedorko L, Djaiani G. Vitamin D: Defense Against Delirium? J Cardiothorac Vasc Anesth. 2020; 34(7): 1780–1782. Epub 20200415. pmid:32359712.
- 6. Bowman K, Jones L, Pilling LC, Delgado J, Kuchel GA, Ferrucci L, et al. Vitamin D levels and risk of delirium: A mendelian randomization study in the UK Biobank. Neurology. 2019; 92(12): e1387–e1394. Epub 20190215. pmid:30770424.
- 7. Barnard K, Colon-Emeric C. Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother. 2010; 8(1): 4–33. pmid:20226390.
- 8. Cui X, McGrath JJ, Burne THJ, Eyles DW. Vitamin D and schizophrenia: 20 years on. Mol Psychiatry. 2021; 26(7): 2708–2720. Epub 20210126. pmid:33500553.
- 9. Harms LR, Burne TH, Eyles DW, McGrath JJ. Vitamin D and the brain. Best Pract Res Clin Endocrinol Metab. 2011; 25(4): 657–669. pmid:21872806.
- 10. Laganà AS, Vitale SG, Ban Frangež H, Vrtačnik-Bokal E, D’Anna R. Vitamin D in human reproduction: the more, the better? An evidence-based critical appraisal. Eur Rev Med Pharmacol Sci. 2017; 21(18): 4243–4251. pmid:29028072.
- 11. Colonese F, Lagana AS, Colonese E, Sofo V, Salmeri FM, Granese R, et al. The pleiotropic effects of vitamin D in gynaecological and obstetric diseases: an overview on a hot topic. Biomed Res Int. 2015; 2015: 986281. Epub 20150427. pmid:26000308.
- 12. Wang XR, Xiao JP, Zhang JJ, Wu YG. Decreased Serum/Plasma Vitamin D levels in SLE Patients: A Meta-Analysis. Curr Pharm Des. 2018; 24(37): 4466–4473. pmid:30636593.
- 13. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7): 1911–1930. Epub 20110606. pmid:21646368.
- 14. Qiu Y, Sessler DI, Chen L, Halvorson S, Cohen B, Bravo M, et al. Preoperative Vitamin D Deficiency Is Associated With Postoperative Delirium in Critically Ill Patients. J Intensive Care Med. 2022; 37(5): 655–662. Epub 20210701. pmid:34196246.
- 15. Schneider AL, Lutsey PL, Alonso A, Gottesman RF, Sharrett AR, Carson KA, et al. Vitamin D and cognitive function and dementia risk in a biracial cohort: the ARIC Brain MRI Study. Eur J Neurol. 2014; 21(9): 1211–1218, e1269-1270. Epub 20140521. pmid:24846449.
- 16. Goodwill AM, Szoeke C. A Systematic Review and Meta-Analysis of The Effect of Low Vitamin D on Cognition. J Am Geriatr Soc. 2017; 65(10): 2161–2168. Epub 20170731. pmid:28758188.
- 17. Groves NJ, McGrath JJ, Burne TH. Vitamin D as a neurosteroid affecting the developing and adult brain. Annu Rev Nutr. 2014; 34: 117–141. pmid:25033060.
- 18. Ford J, Hategan A, Bourgeois JA, Tisi DK, Xiong GL. Hypovitaminosis D in Delirium: a Retrospective Cross-sectional Study. Can Geriatr J. 2013; 16(4): 186–191. Epub 20131203. pmid:24278095.
- 19. Pilling LC, Jones LC, Masoli JAH, Delgado J, Atkins JL, Bowden J, et al. Low Vitamin D Levels and Risk of Incident Delirium in 351,000 Older UK Biobank Participants. J Am Geriatr Soc. 2021; 69(2): 365–372. Epub 20201005. pmid:33017050.
- 20. Morandi A, Barnett N, Miller RR 3rd, Girard TD, Pandharipande PP, Ely EW, et al. Vitamin D and delirium in critically ill patients: a preliminary investigation. J Crit Care. 2013; 28(3): 230–235. Epub 20120809. pmid:22884531.
- 21. Slinin Y, Paudel ML, Taylor BC, Fink HA, Ishani A, Canales MT, et al. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology. 2010; 74(1): 33–41. Epub 20091125. pmid:19940271.
- 22. Overman MJ, Pendleton N, O’Neill TW, Bartfai G, Casanueva FF, Finn JD, et al. Evaluation of cognitive subdomains, 25-hydroxyvitamin D, and 1,25-dihydroxyvitamin D in the European Male Ageing Study. Eur J Nutr. 2017; 56(6): 2093–2103. Epub 20160701. pmid:27370643.
- 23. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283(15): 2008–2012. pmid:10789670.
- 24. Beauchet O, Launay C, de Decker L, Fantino B, Kabeshova A, Annweiler C. Who is at risk of long hospital stay among patients admitted to geriatric acute care unit? Results from a prospective cohort study. J Nutr Health Aging. 2013; 17(8): 695–699. pmid:24097024.
- 25. Torbergsen AC, Watne LO, Frihagen F, Wyller TB, Brugaard A, Mowe M. Vitamin deficiency as a risk factor for delirium. European Geriatric Medicine. 2015; 6(4): 314–318. https://doi.org/10.1016/j.eurger.2014.09.002.
- 26. Ingstad F, Solberg LB, Nordsletten L, Thorsby PM, Hestnes I, Frihagen F. Vitamin D status and complications, readmissions, and mortality after hip fracture. Osteoporos Int. 2021; 32(5): 873–881. Epub 20201117. pmid:33201249.
- 27. Velayati A, Vahdat Shariatpanahi M, Dehghan S, Zayeri F, Vahdat Shariatpanahi Z. Vitamin D and Postoperative Delirium After Coronary Artery Bypass Grafting: A Prospective Cohort Study. J Cardiothorac Vasc Anesth. 2020; 34(7): 1774–1779. Epub 20200212. pmid:32156511.
- 28. Tumer NB, Tekeli Kunt A, Gunaydin S, Ozisik K. Preoperative Vitamin D Level is Associated with Postoperative Delirium After Cardiac Surgery in Patients Over 65 Years of Age. Heart Surg Forum. 2020; 23(3): E264–E269. Epub 20200505. pmid:32524976.
- 29. Chouët J, Sacco G, Karras SN, Llewellyn DJ, Sánchez-Rodríguez D, Annweiler C. Vitamin D and Delirium in Older Adults: A Case-Control Study in Geriatric Acute Care Unit. Frontiers in Neurology. 2020; 11. pmid:33071932
- 30. Quraishi SA, Litonjua AA, Elias KM, Gibbons FK, Giovannucci E, Camargo CA, et al. Association between pre-hospital vitamin D status and hospital-acquired new-onset delirium. British Journal of Nutrition. 2015; 113(11): 1753–1760. pmid:26067807
- 31. Annweiler C, Llewellyn DJ, Beauchet O. Low serum vitamin D concentrations in Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis. 2013; 33(3): 659–674. pmid:23042216.
- 32. Balion C, Griffith LE, Strifler L, Henderson M, Patterson C, Heckman G, et al. Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology. 2012; 79(13): 1397–1405. pmid:23008220.
- 33. Meng L, Wang Z, Ming YC, Shen L, Ji HF. Are micronutrient levels and supplements causally associated with the risk of Alzheimer’s disease? A two-sample Mendelian randomization analysis. Food Funct. 2022; 13(12): 6665–6673. Epub 20220620. pmid:35647710.
- 34. Wang L, Qiao Y, Zhang H, Zhang Y, Hua J, Jin S, et al. Circulating Vitamin D Levels and Alzheimer’s Disease: A Mendelian Randomization Study in the IGAP and UK Biobank. Journal of Alzheimer’s Disease. 2020; 73(2): 609–618. pmid:31815694
- 35. Larsson S, Traylor M, Markus H, Michaëlsson K. Serum Parathyroid Hormone, 25-Hydroxyvitamin D, and Risk of Alzheimer’s Disease: A Mendelian Randomization Study. Nutrients. 2018; 10(9). pmid:30200567
- 36. Mokry LE, Ross S, Morris JA, Manousaki D, Forgetta V, Richards JB. Genetically decreased vitamin D and risk of Alzheimer disease. Neurology. 2016; 87(24): 2567–2574. Epub 20161116. pmid:27856775.
- 37. Maddock J, Zhou A, Cavadino A, Kuźma E, Bao Y, Smart MC, et al. Vitamin D and cognitive function: A Mendelian randomisation study. Scientific Reports. 2017; 7(1). pmid:29038561
- 38. Simone MJ, Tan ZS. The role of inflammation in the pathogenesis of delirium and dementia in older adults: a review. CNS Neurosci Ther. 2011; 17(5): 506–513. Epub 20100611. pmid:20553303.
- 39. Cerejeira J, Firmino H, Vaz-Serra A, Mukaetova-Ladinska EB. The neuroinflammatory hypothesis of delirium. Acta Neuropathol. 2010; 119(6): 737–754. Epub 20100324. pmid:20309566.
- 40. Cunningham C. Systemic inflammation and delirium: important co-factors in the progression of dementia. Biochem Soc Trans. 2011; 39(4): 945–953. pmid:21787328.
- 41. Zhou A, Hypponen E. Vitamin D deficiency and C-reactive protein: a bidirectional Mendelian randomization study. Int J Epidemiol. 2022. Epub 20220517. pmid:35579027.
- 42. Guillot X, Semerano L, Saidenberg-Kermanac’h N, Falgarone G, Boissier MC. Vitamin D and inflammation. Joint Bone Spine. 2010; 77(6): 552–557. Epub 20101109. pmid:21067953.
- 43. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357(3): 266–281. pmid:17634462.
- 44. Sempos CT, Williams EL, Carter GD, Jones J, Camara JE, Burdette CQ, et al. Assessment of serum total 25-hydroxyvitamin D assays for Vitamin D External Quality Assessment Scheme (DEQAS) materials distributed at ambient and frozen conditions. Anal Bioanal Chem. 2022; 414(2): 1015–1028. Epub 20211109. pmid:34750644.
- 45. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003; 77(1): 204–210. pmid:12499343.
- 46. McNally JD, Iliriani K, Pojsupap S, Sampson M, O’Hearn K, McIntyre L, et al. Rapid normalization of vitamin D levels: a meta-analysis. Pediatrics. 2015; 135(1): e152–166. Epub 20141215. pmid:25511115.
- 47. Perez-Castrillon JL, Usategui-Martin R, Pludowski P. Treatment of Vitamin D Deficiency with Calcifediol: Efficacy and Safety Profile and Predictability of Efficacy. Nutrients. 2022; 14(9). Epub 20220505. pmid:35565910.
- 48. Wimalawansa SJ. Rapidly Increasing Serum 25(OH)D Boosts the Immune System, against Infections-Sepsis and COVID-19. Nutrients. 2022; 14(14). Epub 20220721. pmid:35889955.